CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change of -$29.00 thousand for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanOtherChanges · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2025 was -$29.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2024 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2021 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2020 was -$429.00K.
| Period end | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 12 month | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 12 month as first filed |
|---|---|---|
| 2025-12-27 | -$29.00K 10-K · filed 2026-02-18 | |
| 2024-12-28 | $0.00 10-K · filed 2026-02-18 | |
| 2021-12-25 | $0.00 10-K · filed 2022-02-16 | |
| 2020-12-26 | -$429.00K 10-K · filed 2022-02-16 | |
| 2019-12-28 | -$850.00K 10-K · filed 2021-02-17 | |
| 2018-12-29 | -$1.50M 10-K · filed 2020-02-11 | $1.50M 10-K · filed 2019-02-13 |
| 2017-12-30 | $0.00 10-K · filed 2019-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |